BlackRock’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$835K Sell
411,307
-745,284
-64% -$1.51M ﹤0.01% 4239
2025
Q1
$2.16M Sell
1,156,591
-1,055,931
-48% -$1.97M ﹤0.01% 3927
2024
Q4
$5.97M Sell
2,212,522
-461,789
-17% -$1.25M ﹤0.01% 3606
2024
Q3
$10.1M Buy
2,674,311
+66,880
+3% +$253K ﹤0.01% 3360
2024
Q2
$10.4M Buy
2,607,431
+65,479
+3% +$261K ﹤0.01% 3320
2024
Q1
$7.52M Buy
2,541,952
+123,932
+5% +$367K ﹤0.01% 3444
2023
Q4
$12.1M Buy
2,418,020
+2,414,002
+60,080% +$12.1M ﹤0.01% 3225
2023
Q3
$11.5K Hold
4,018
﹤0.01% 5123
2023
Q2
$11.9K Hold
4,018
﹤0.01% 5154
2023
Q1
$9.4K Hold
4,018
﹤0.01% 5247
2022
Q4
$8.2K Sell
4,018
-363,975
-99% -$743K ﹤0.01% 5401
2022
Q3
$1.16M Sell
367,993
-10,239
-3% -$32.4K ﹤0.01% 4340
2022
Q2
$1.37M Buy
378,232
+85,959
+29% +$310K ﹤0.01% 4316
2022
Q1
$1.17M Buy
292,273
+4,685
+2% +$18.7K ﹤0.01% 4526
2021
Q4
$1.42M Sell
287,588
-19,643
-6% -$97.2K ﹤0.01% 4469
2021
Q3
$2.06M Sell
307,231
-41,232
-12% -$277K ﹤0.01% 4251
2021
Q2
$2.76M Sell
348,463
-276,654
-44% -$2.19M ﹤0.01% 4063
2021
Q1
$4.76M Sell
625,117
-31,038
-5% -$236K ﹤0.01% 3903
2020
Q4
$3.39M Sell
656,155
-38,867
-6% -$201K ﹤0.01% 3783
2020
Q3
$3.39M Sell
695,022
-60,432
-8% -$295K ﹤0.01% 3646
2020
Q2
$5.08M Buy
755,454
+164,424
+28% +$1.11M ﹤0.01% 3444
2020
Q1
$4.08M Sell
591,030
-32,052
-5% -$221K ﹤0.01% 3376
2019
Q4
$5.31M Sell
623,082
-39,093
-6% -$333K ﹤0.01% 3432
2019
Q3
$3.28M Sell
662,175
-10,413
-2% -$51.5K ﹤0.01% 3559
2019
Q2
$3.73M Sell
672,588
-25,414
-4% -$141K ﹤0.01% 3558
2019
Q1
$3.53M Buy
698,002
+53,327
+8% +$269K ﹤0.01% 3493
2018
Q4
$6.09M Buy
+644,675
New +$6.09M ﹤0.01% 3306